ConductScience.org, home

Paper36652154

Impact of silencing eEF2K expression on the malignant properties of chordoma.

Aydemir E and 5 others. Mol Biol Rep, 2023. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Impact of silencing eEF2K expression on the malignant properties of chordoma. Papers, record 36652154. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36652154

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Impact of silencing eEF2K expression on the malignant properties of chordoma.
PubMed
Journal
Mol Biol Rep
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.14
iCite
Revised in PubMed
2026-10-30
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Aydemir EEsrahttps://orcid.org/0000-0002-6965-2838
2Tüysüz ECEmre Canhttps://orcid.org/0000-0002-2264-0303
3Bayrak ÖFÖmer Farukhttps://orcid.org/0000-0001-7562-6604
4Tecimel DDidemhttps://orcid.org/0000-0002-0776-1238
5Hızlı-Deniz AAAyşen Aslıhttps://orcid.org/0000-0003-0490-7737
6Şahin FFikrettinhttps://orcid.org/0000-0003-1503-5567

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Elongation Factor 2 KinaseMajor topic
ChordomaMajor topic
Humans
Phosphorylation
Cell Line
Signal Transduction

References61

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121531565The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation.Trends Biochem Sci2011https://conductscience.org/library/papers/21531565PubMed
223182879Integrated regulation of autophagy and apoptosis by EEF2K controls cellular fate and modulates the efficacy of curcumin and velcade against tumor cells.Autophagy2013https://conductscience.org/library/papers/23182879PubMed
32390990Functional properties of phosphorylated elongation factor 2.Eur J Biochem1990https://conductscience.org/library/papers/2390990PubMed
428060762Eukaryotic elongation factor 2 is a prognostic marker and its kinase a potential therapeutic target in HCC.Oncotarget2017https://conductscience.org/library/papers/28060762PubMed
534532346Insights Into the Pathologic Roles and Regulation of Eukaryotic Elongation Factor-2 Kinase.Front Mol Biosci2021https://conductscience.org/library/papers/34532346PubMed
629050305Calyxin Y sensitizes cisplatin-sensitive and resistant hepatocellular carcinoma cells to cisplatin through apoptotic and autophagic cell death via SCF βTrCP-mediated eEF2K degradation.Oncotarget2017https://conductscience.org/library/papers/29050305PubMed
734352439eEF2K as a novel metastatic and prognostic biomarker in gastric cancer patients.Pathol Res Pract2021https://conductscience.org/library/papers/34352439PubMed
835026050Weekly cisplatin with or without imatinib in advanced chordoma: A retrospective case-series analysis from the Italian Rare Cancers Network.Cancer2022https://conductscience.org/library/papers/35026050PubMed
92662114Chordoma: a critical review of diagnosis and treatment.Orthop Clin North Am1989https://conductscience.org/library/papers/2662114PubMed
1019570961Response to imatinib plus sirolimus in advanced chordoma.Ann Oncol2009https://conductscience.org/library/papers/19570961PubMed
1119401700Potential therapeutic targets for chordoma: PI3K/AKT/TSC1/TSC2/mTOR pathway.Br J Cancer2009https://conductscience.org/library/papers/19401700PubMed
1230268477Elongation factor-2 kinase (eEF-2K) expression is associated with poor patient survival and promotes proliferation, invasion and tumor growth of lung cancer.Lung Cancer2018https://conductscience.org/library/papers/30268477PubMed
1325464034Stress-mediated translational control in cancer cells.Biochim Biophys Acta2015https://conductscience.org/library/papers/25464034PubMed
1426806303Eukaryotic elongation factor 2 kinase as a drug target in cancer, and in cardiovascular and neurodegenerative diseases.Acta Pharmacol Sin2016https://conductscience.org/library/papers/26806303PubMed
1522911754Targeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancer.PLoS One2012https://conductscience.org/library/papers/22911754PubMed
1611227920Chordoma: incidence and survival patterns in the United States, 1973-1995.Cancer Causes Control2001https://conductscience.org/library/papers/11227920PubMed
1722002331Establishment and detailed functional and molecular genetic characterisation of a novel sacral chordoma cell line, MUG-Chor1.Int J Oncol2012https://conductscience.org/library/papers/22002331PubMed
1830814891The effect of TWIST silencing in metastatic chordoma cells.Turk J Biol2018https://conductscience.org/library/papers/30814891PubMed
1927756261Inhibition of eEF-2 kinase sensitizes human nasopharyngeal carcinoma cells to lapatinib-induced apoptosis through the Src and Erk pathways.BMC Cancer2016https://conductscience.org/library/papers/27756261PubMed
2025666164Preclinical and clinical development of siRNA-based therapeutics.Adv Drug Deliv Rev2015https://conductscience.org/library/papers/25666164PubMed

See all 61 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
39738914Combinatorial therapies for epigenetic, immunotherapeutic, and genetic targeting of chordoma.J Neurooncol2025https://conductscience.org/library/papers/39738914

Source PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
EEF21938PubTator's text mininghttps://conductscience.org/library/genes/1938NCBI Gene
EEF2K29904PubTator's text mininghttps://conductscience.org/library/genes/29904NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36652154

GET https://conductscience.org/api/papers/v1/36652154/references?page=2